Book Closure

SUN PHARMA ADVANCED RESEARCH COMPANY LTD.

NSE : SPARCBSE : 532872ISIN CODE : INE232I01014Industry : Business SupportHouse : Sun Pharma
BSE203.25-2.85 (-1.38 %)
PREV CLOSE ( ) 206.10
OPEN PRICE ( ) 204.00
BID PRICE (QTY) 202.70 (500)
OFFER PRICE (QTY) 203.10 (198)
VOLUME 54750
TODAY'S LOW / HIGH ( )202.85 207.10
52 WK LOW / HIGH ( )108.2 289
NSE203.25-2.62 (-1.27 %)
PREV CLOSE( ) 205.87
OPEN PRICE ( ) 205.87
BID PRICE (QTY) 203.22 (12)
OFFER PRICE (QTY) 203.34 (15)
VOLUME 539663
TODAY'S LOW / HIGH( ) 201.25 206.96
52 WK LOW / HIGH ( )108 289

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.